Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Angi Inc
ANGI
$229M
| $3.45M | ﹤0.01% |
28,371
-625
| -2% | -$57K |
|
|
ODT
2202
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $3.45M | ﹤0.01% |
81,422
+14,592
| +22% | +$472K |
|
2203
Cato Corp
CATO
$68.3M
| $3.44M | ﹤0.01% |
420,472
-58,837
| -12% | -$580K |
|
|
NEX
2204
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $3.43M | ﹤0.01% |
1,401,160
+226,171
| +19% | +$553K |
|
2205
Black Diamond Therapeutics
BDTX
$96.8M
| $3.43M | ﹤0.01% |
81,255
+55,702
| +218% | +$2.05M |
|
|
EIDX
2206
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $3.4M | ﹤0.01% |
71,426
+24,200
| +51% | +$1.13M |
|
2207
Bank of Marin Bancorp
BMRC
$472M
| $3.4M | ﹤0.01% |
102,126
+24,771
| +32% | +$784K |
|
|
TRTX
2208
TPG RE Finance Trust
TRTX
$612M
| $3.4M | ﹤0.01% |
395,706
+62,870
| +19% | +$457K |
|
2209
Camden National
CAC
$978M
| $3.39M | ﹤0.01% |
98,200
+4,048
| +4% | +$128K |
|
2210
e.l.f. Beauty
ELF
$4.89B
| $3.38M | ﹤0.01% |
177,370
+15,415
| +10% | +$221K |
|
2211
Washington Trust Bancorp
WASH
$743M
| $3.38M | ﹤0.01% |
103,119
+9,011
| +10% | +$295K |
|
2212
Puma Biotechnology
PBYI
$404M
| $3.36M | ﹤0.01% |
322,497
+12,735
| +4% | +$132K |
|
2213
Ecovyst
ECVT
$1.32B
| $3.36M | ﹤0.01% |
253,932
+12,751
| +5% | +$150K |
|
2214
Expro Ltd
XPRO
$1.79B
| $3.35M | ﹤0.01% |
250,744
+33,319
| +15% | +$449K |
|
|
MTSC
2215
DELISTED
MTS Systems Corp
MTSC
| $3.34M | ﹤0.01% |
189,811
+18,278
| +11% | +$338K |
|
2216
Republic Bancorp
RBCAA
$1.95B
| $3.33M | ﹤0.01% |
101,769
+3,784
| +4% | +$120K |
|
2217
The Bancorp
TBBK
$2.79B
| $3.33M | ﹤0.01% |
339,317
+23,331
| +7% | +$176K |
|
|
NFBK
2218
DELISTED
Northfield Bancorp
NFBK
| $3.32M | ﹤0.01% |
288,502
+16,522
| +6% | +$179K |
|
|
HOME
2219
DELISTED
At Home Group Inc.
HOME
| $3.32M | ﹤0.01% |
511,263
+110,112
| +27% | +$450K |
|
2220
Ecopetrol
EC
$34.5B
| $3.31M | ﹤0.01% |
297,297
+3,232
| +1% | +$35K |
|
|
LDL
2221
DELISTED
Lydall, Inc.
LDL
| $3.31M | ﹤0.01% |
243,719
-5,470
| -2% | -$60.5K |
|
2222
Cass Information Systems
CASS
$714M
| $3.28M | ﹤0.01% |
83,974
+5,231
| +7% | +$197K |
|
2223
RPC Inc
RES
$1.24B
| $3.28M | ﹤0.01% |
1,063,721
-42,813
| -4% | -$130K |
|
2224
Pacific Biosciences
PACB
$435M
| $3.27M | ﹤0.01% |
948,189
+65,560
| +7% | +$223K |
|
|
EGRX
2225
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.27M | ﹤0.01% |
68,194
+8,047
| +13% | +$401K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.